Adverse events · Patients with active Crohn's disease
Azathioprine or 6‐mercaptopurine may leads to lower adverse events compared with methotrexate (low certainty).
1 finding from 1 review
Withdrawals due to adverse events · Patients with active Crohn's disease
It is very uncertain whether azathioprine or 6‐mercaptopurine changes withdrawals due to adverse events compared with methotrexate (very low certainty).
1 finding from 1 review
Maintenance of remission · maintenance of remission in Crohn's disease
It is very uncertain whether 6‐Mercaptopurine changes maintenance of remission compared with methotrexate (very low certainty).
1 finding from 1 review
Adverse events · maintenance of remission in Crohn's disease
It is very uncertain whether 6‐Mercaptopurine changes adverse events compared with methotrexate (very low certainty).
1 finding from 1 review
Withdrawals due to adverse events · maintenance of remission in Crohn's disease
It is very uncertain whether 6‐Mercaptopurine changes withdrawals due to adverse events compared with methotrexate (very low certainty).
1 finding from 1 review
Serious adverse events · maintenance of remission in Crohn's disease
It is very uncertain whether 6‐Mercaptopurine changes serious adverse events compared with methotrexate (very low certainty).
1 finding from 1 review
Intervention not reported
ACR 50 American College of Rheumatology improvement criteria · patients with rheumatoid arthritis
The intervention probably leads to higher ACR 50 American College of Rheumatology improvement criteria (moderate certainty).
1 finding from 1 review
Intervention not reported
Remission3 · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
Functional Status Health Assessment Questionnaire Disability Index . Scale from: 0 to 3 · patients with rheumatoid arthritis
1 finding from 1 review
Intervention not reported
Health‐Related Quality of Life at least 20% improvement · patients with rheumatoid arthritis
The intervention showed no clear difference in health‐Related Quality of Life at least 20% improvement (moderate certainty).
1 finding from 1 review
Intervention not reported
Radiographic Progression Increase in erosion scores of > 3 units · patients with rheumatoid arthritis
The intervention probably leads to lower radiographic Progression Increase in erosion scores of > 3 units (moderate certainty).
1 finding from 1 review
Intervention not reported
Discontinuations due to adverse events · patients with rheumatoid arthritis
The intervention leads to higher discontinuations due to adverse events (high certainty).
1 finding from 1 review
Intervention not reported
Serious Adverse Events · patients with rheumatoid arthritis
The intervention showed no clear difference in serious Adverse Events (moderate certainty).
1 finding from 1 review
ASAS 40 · Patients with AS
The review found no eligible studies for this question.
1 finding from 1 review
Partial remission ( · Patients with AS
The review found no eligible studies for this question.
1 finding from 1 review
BASFI (score from 0 to 10, 0=excellent, 10=poor function) · Patients with AS
1 finding from 1 review
X‐Ray of the spine · Patients with AS
The review found no eligible studies for this question.
1 finding from 1 review
MRI · Patients with AS
The review found no eligible studies for this question.
1 finding from 1 review
Serious adverse event · Patients with AS
The review found no eligible studies for this question.
1 finding from 1 review
Withdrawals due to any reason · Patients with AS
MTX treated showed no clear difference in withdrawal for any reason compared with no MTX treated (low certainty).
1 finding from 1 review